The role of SGLT-2 inhibitors on health-related quality of life, exercise capacity, and volume depletion in patients with chronic heart failure: a meta-analysis of randomized controlled trials.
Lingjiao WangJing YuZhimin GuoYiqi WangZhiqiang YangChunhua ZhouPublished in: International journal of clinical pharmacy (2023)
SGLT-2 inhibitors could improve HRQoL and exercise capacity in patients with chronic HF. SGLT-2 inhibitors did not have an impact on volume depletion.